Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats (Q45081784)

9 December 2017

title

Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats (English)

1 reference

9 December 2017

4

1 reference

9 December 2017

Athina Markou

1

1 reference

9 December 2017

Amanda A Harrison

series ordinal

2

1 reference

9 December 2017

Jessica Chevrette

series ordinal

3

1 reference

9 December 2017

publication date

25 September 2004

1 reference

9 December 2017

1 reference

9 December 2017

volume

178

1 reference

9 December 2017

issue

2-3

1 reference

9 December 2017

page(s)

133-142

1 reference

Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs

9 December 2017

cites work

1 reference

12 December 2020

Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.

1 reference

12 December 2020

Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study

1 reference

12 December 2020

Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-H

1 reference

12 December 2020

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

1 reference

12 December 2020

Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?

1 reference

12 December 2020

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

1 reference

12 December 2020

Pindolol augmentation of antidepressant therapy.

1 reference

12 December 2020

Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei

1 reference

12 December 2020

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

1 reference

12 December 2020

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial

1 reference

12 December 2020

Parker and Radow test of drug withdrawal aversion: opposite effect in rats chronically infused with sufentanil or amphetamine.

1 reference

12 December 2020

A 'crash' course on psychostimulant withdrawal as a model of depression

1 reference

12 December 2020

The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor

1 reference

12 December 2020

Differential functional activity of 5-hydroxytryptamine receptor ligands and beta adrenergic receptor antagonists at 5-hydroxytryptamine1B receptor sites in Chinese hamster lung fibroblasts and opossum renal epithelial cells.

1 reference

12 December 2020

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study

1 reference

12 December 2020

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

1 reference

12 December 2020

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

12 December 2020

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

1 reference

12 December 2020

Pindolol and the acceleration of the antidepressant response

1 reference

12 December 2020

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

12 December 2020

Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites

1 reference

12 December 2020

Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors

1 reference

12 December 2020

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

1 reference

12 December 2020

Response sensitization and depression following long-term amphetamine treatment in a self-stimulation paradigm

1 reference

12 December 2020

Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours.

1 reference

12 December 2020

Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine

1 reference

12 December 2020

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

1 reference

12 December 2020

The neuropharmacology of serotonin and noradrenaline in depression.

1 reference

12 December 2020

(-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.

1 reference

12 December 2020

Amphetamine and the reward system: Evidence for tolerance and post-drug depression

1 reference

12 December 2020

The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat.

1 reference

12 December 2020

Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies

1 reference

12 December 2020

Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats

1 reference

12 December 2020

Pindolol does not act only on 5-HT1A receptors in augmenting antidepressant activity in the mouse forced swimming test

1 reference

12 December 2020

Current advances and trends in the treatment of depression

1 reference

12 December 2020

A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients

1 reference

12 December 2020

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

12 December 2020

Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats

1 reference

12 December 2020

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

1 reference

12 December 2020

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

12 December 2020

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

1 reference

12 December 2020

5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus

1 reference

12 December 2020

Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo

1 reference

12 December 2020

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1 reference

12 December 2020

The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol

1 reference

12 December 2020

Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo

1 reference

12 December 2020

A potential 5-HT1A receptor antagonist: p-MPPI.

1 reference

12 December 2020

Inhibition of norepinephrine uptake in patients with major depression treated with paroxetine

1 reference

12 December 2020

Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: role of presynaptic 5-HT1A receptors

1 reference

12 December 2020

Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories

1 reference

12 December 2020

Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex

1 reference

12 December 2020

Euphorigenic drugs: effects on the reward pathways of the brain

1 reference

12 December 2020

Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study

1 reference

12 December 2020

Neurobiological evidence for hedonic allostasis associated with escalating cocaine use.

1 reference

12 December 2020

Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex

1 reference

12 December 2020

Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency

1 reference

12 December 2020

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

12 December 2020

Construct validity of a self-stimulation threshold paradigm: Effects of reward and performance manipulations

1 reference

12 December 2020

Fluoxetine: clinical pharmacology and physiologic disposition

1 reference

12 December 2020

The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression

1 reference

12 December 2020

10.1007/S00213-004-2008-2

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

1000745744

0 references

1 reference